Biomarkers Predict Brain Tumor's Response To Therapy
Wednesday, June 24, 2009 - 00:14
in Health & Medicine
A new biomarker may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.